Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-03-07
2009-08-25
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387900, C530S388100, C530S388260, C530S389100, C530S389300, C424S130100, C424S139100, C424S141100, C424S146100, C424S158100, C435S326000, C435S338000, C435S346000
Reexamination Certificate
active
07579447
ABSTRACT:
Lipoprotein Lipase like polypeptides, nucleic acids encoding said polypeptides, antisense sequences, and antibodies to said polypeptides are disclosed. Also disclosed are methods for the preparation of said polypeptides in a recombinant system and for the use of said polypeptides to screen for agonists and or antagonists of said polypeptides. Also disclosed are methods and compositions for the treatment of disorders of lipid metabolism.
REFERENCES:
patent: 4944944 (1990-07-01), Tang et al.
patent: 5364777 (1994-11-01), Spencer
patent: 5616483 (1997-04-01), Bjursell et al.
patent: 5691181 (1997-11-01), Lowe
patent: 5858755 (1999-01-01), Lowe
patent: 5976855 (1999-11-01), Svendsen et al.
patent: 5998189 (1999-12-01), Blanchard et al.
patent: 6074863 (2000-06-01), Svendsen et al.
patent: 6159947 (2000-12-01), Schweighoffer et al.
patent: 6337187 (2002-01-01), Kapeller-Libermann
patent: 6395530 (2002-05-01), Jaye et al.
patent: 6558936 (2003-05-01), Khodadoust et al.
patent: 6797502 (2004-09-01), Kapeller-Libermann
patent: 6864064 (2005-03-01), Kapeller-Libermann
patent: 7008776 (2006-03-01), Jaye et al.
patent: 7056720 (2006-06-01), Jaye et al.
patent: 2003/0108538 (2003-06-01), Jaye et al.
patent: 2006/0088504 (2006-04-01), Jaye et al.
patent: WO 94/02610 (1994-02-01), None
patent: WO 94/20619 (1994-09-01), None
patent: WO 94/29446 (1994-12-01), None
patent: 96/38170 (1996-12-01), None
Attwood Science 2000; 290:471-473.
Lederman et al. Molecular Immunology 28: 1171-1181, 1991.
Li et al. PNAS 77: 3211-3214, 1980.
Östlund-Lindquist Biochem. J. 1979, 179:555-559.
Falkenberge et al. (J. Clin. Chem. Clin. Biochem. 1984, 22:867-882.
Skolnick et al. Trends in Biotech. 2000; 18(1):34-39.
Cooper, D. et al., Genbank Database, Accession No. P11602 (1989).
Eisenberg, S. et al., Lipoprotein Lipase Enhances Binding of Lipoproteins to Heparan Sulfate on Cell Surfaces and Extracellular Matrix,J. Clin. Invest. (Nov. 1992), 90: 2013-2021.
Goldberg, I.J. et al., Lipoprotein Metabolism During Acute Inhibition of Lipoprotein Lipase in the Cynomolgus Monkey,J. Clin. Invest. (Feb. 1988), 81: 561-568.
Goldberg, I.J. et al., Lipoprotein Metabolism During Acute Inhibition of Hepatic Triglyceride Lipase in the Cynomolgus Monkey,J. Clin. Invest. (Dec. 1982), 70: 1184-1192.
Cheng, C. et al., Binding of Lipoprotein Lipase to Endothelial Cells in Culture,J. Biol. Chem. (Dec. 25, 1981), 256: 12893-12898.
Shimada, K. et al., Involvement of Cell Surface Heparin Sulfate in the Binding of Lipoprotein Lipase to Cultured Bovine Endothelial Cells,J. Clin. Invest. (Oct. 1981), 68: 995-1002.
Saxena, U. et al., Identification and Characterization of the Endothelial Cell Surface Lipoprotein Lipase Receptor,J. Biol. Chem. (Sep. 15, 1991), 266: 17516-17521.
Mulder, M. et al., Heparan Sulfate Proteoglycans are Involved in the Lipoprotein Lipase-Mediated Enhancement of the Cellular Binding of Very Low Density and Low Density Lipoproteins,Biochem. Biophys. Res. Commun. (Jun. 15, 1992), 185: 582-587.
Tsuchiya, S. et al., Establishment and Characterization of a Human Acute Monocytic Leukemia Cell Line (THP-1),Int. J. Cancer(1980), 26: 171-176.
Goldberg, I.J., Lipoprotein Lipase and Lipolysis: Central Roles in Lipoprotein Metabolism and Atherogenesis,J. Lipid Res. (1996), 37: 693-707.
Gordon, D.J. and B.M. Rifkind, High Density Lipoprotein—The Clinical Implications of Recent Studies,N. Engl. J. Med. (Nov. 9, 1989), 321: 1311-1316.
Breslow, J.L., The Metabolic Basis of Inherited Disease, New York: McGraw Hill, 1995: 2031-2052.
Heller, D.A. et al., Genetic and Environmental Influences on Serum Lipid Levels in Twins,N. Engl. J. Med. (Apr. 22, 1993), 328: 1150-1156.
Murthy, V. et al., Molecular Pathobiology of the Human Lipoprotein Lipase Gene,Pharmacol. Ther. (1996), 70: 101-135.
Bensadoun, A. and D.E. Berryman, Genetics and Molecular Biology of Hepatic Lipase,Curr. Opin. Lipidol. (1996), 7: 77-81.
Guerra, R. et al., A Hepatic Lipase (LIPC) Allele Associated with High Plasma Concentrations of High Density Lipoprotein Cholesterol,Proc. Natl. Acad. Sci. USA(Apr. 1997), 94: 4532-4537.
LIPID Study Group, Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels,N. Engl. J. Med. (Nov. 5, 1998), 339: 1349-1357.
Kannel, W.B., Range of Serum Cholesterol Values in the Population Developing Coronary Artery Disease,Am. J. Cardiol. (Sep. 28, 1995), 76: 69C-77C.
4S Group, Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease,Lancet(Nov. 19, 1994), 344: 1383-1389.
Sacks, F.M. et al., The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels,N. Engl. J. Med. (Oct. 3, 1996), 335: 1001-1009.
Shepherd, J. et al., Prevention of Coronary Heart Disease with Pravastatin in Man with Hypercholesterolemia,N. Engl. J. Med. (Nov. 16, 1995), 333: 1301-1307.
Downs, J.R. et al., Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels,JAMA(May 27, 1998), 279: 1615-1622.
Grundy, S.M., Statin Trials and Goals of Cholelsterol-Lowering Therapy,Circulation(1998), 97: 1436-1439.
Hegele, R.A. et al., Hepatic Lipase Deficiency: Clinical, Biochemical, and Molecular Genetics Characteristics,Arterioscler. Thromb. (May 1993), 13: 720-728.
Homanics, G.E. et al., Mild Dyslipidemia in Mice Following Targeted Inactivation of the Hepatic Lipase Gene,J. Biol. Chem. (1995), 270: 2974-2980.
Mezdour, H. et al., Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice,J. Biol. Chem. (May 23, 1997), 272: 13570-13575.
Busch, S.J. et al., Human Hepatic Triglyceride Lipase Expression Reduces High Density Lipoprotein and Aortic Cholesterol in Cholesterol-fed Transgenic Mice,J. Biol. Chem. (Jun. 10, 1994), 269: 16376-16382.
Fan, J. et al., Overexpression of Hepatic Lipase in Transgenic Rabbits Leads to a Marked Reduction of Plasma High Density Lipoproteins and Intermediate Density Lipoproteins,Proc. Natl. Acad. Sci. USA(Aug. 1994), 91: 8724-28.
Tabas, I. et al., Lipoprotein Lipase and Sphingomyelinase Synergistically Enhance the Association of Atherogenic Lipoproteins with Smooth Muscle Cells and Extracellular Matrix,J. Biol. Chem. (Sep. 25, 1993), 268: 20419-32.
Kozarsky, K.F. et al., Overexpression of the HDL Receptor SR-BI Alters Plasma HDL and Bile Cholesterol Levels,Nature(May 22, 1997), 387: 414-417.
Mahley, R.W. and Z. Ji, Remnant Lipoprotein Metabolism: Key Pathways Involving Cell-Surface Heparan Sulfate Proteoglycans and Apolipoprotein E,J. Lipid Res. (1990), 40: 1-16.
Farese, R.V. and J. Herz, Cholesterol Metabolism and Embryogenesis,Trends Genet. (Mar. 1998), 14: 115-120.
Grosschedl, R. et al., Introduction of a μ Immunoglobulin Gene into the Mouse Germ Line: Specific Expression in Lymphoid Cells and Synthesis of Functional Antibody,Cell(Oct. 1984), 38: 647-658.
Mark, G.E. and E.A. Padlan,Humanization of Monoclonal Antibodies, inThe Handbook of Experimental Pharmacology, vol. 113, New York: Springer-Verlag, 1994: 105-134.
Camps, L. et al., Lipoprotein Lipase: cellular Origin and Functional Distribution,Am. J. Physiol. (1990), 258: C673-C681.
Semenkovich, C.F. et al., Lipoprotein Lipase and Hepatic Lipase mRNA Tissue Specific Expression, Developmental Regulation, and Evolution,J. Lipid Res. (1989), 30: 423-431.
Verhoeven, A.J.M. and H. Jansen, Hepatic Lipase mRNA is Expressed in Rat and Human Steroidogenic Organs,Biochim. Biophys. Acta(1994), 1211: 121-124.
Maciag, T. et al., An Endothelial Cell Growth Factor From Bovine Hypothalamus: Identification and Partial Characterization,Proc. Natl. Acad. Sci. USA(Nov. 1979), 76: 5674-5678.
Rothwell, J.E. and M.C. Elphick, Lipoprotein Lipase Activity in Human and Guinea-pig Placenta,J. Dev. Physiol. (1982), 4: 153-159.
Jameson, B.A. and H. Wolf, The Antigenic Index: A Novel Algorithm for Predicting Antigenic Determinants,Comput. Applic. in the Biosciences(Mar. 1988), 4: 181-186.
Amman, E. et al., Tightly Regula
Amin Dilip V.
Doan Kim-Anh Thi
Jaye Michael C.
Krawiec John A.
Lynch Kevin J.
Aventis Pharmaceuticals Inc.
Fox Rothschild LLP
Gambel Phillip
Wen Sharon
LandOfFree
Antibodies against LLG polypeptides of the triacylglycerol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against LLG polypeptides of the triacylglycerol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against LLG polypeptides of the triacylglycerol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4110431